Hengrui Medicine: Net profit 7.711 billion yuan in 2025, a year-on-year increase of 21.69%

Hengrui Pharmaceutical announced that its operating income in 2025 was 31.629 billion yuan, a year-on-year increase of 13.02%. Net profit was 7.711 billion yuan, an increase of 21.69% year-on-year. The company's board of directors approved a profit distribution plan or a capital reserve capitalization plan for the reporting period: based on the share capital on the dividend distribution record date, a cash dividend of 2 yuan per 10 shares will be distributed to all shareholders.